Hilltop Holdings Inc. Lowers Stock Holdings in CVS Health Corporation $CVS

Hilltop Holdings Inc. lowered its position in CVS Health Corporation (NYSE:CVS) by 54.7% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 7,949 shares of the pharmacy operator’s stock after selling 9,604 shares during the period. Hilltop Holdings Inc.’s holdings in CVS Health were worth $571,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of CVS. Caitong International Asset Management Co. Ltd grew its position in shares of CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 281 shares in the last quarter. Swiss RE Ltd. bought a new position in CVS Health in the 4th quarter worth approximately $26,000. Mcguire Capital Advisors Inc. purchased a new stake in CVS Health during the 4th quarter valued at approximately $28,000. Sankala Group LLC bought a new stake in shares of CVS Health during the fourth quarter valued at approximately $28,000. Finally, Global Trust Asset Management LLC lifted its holdings in shares of CVS Health by 344.8% in the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 300 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

Insider Activity at CVS Health

In other news, Director Larry Robbins sold 370,462 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $93.45, for a total value of $34,619,673.90. Following the completion of the sale, the director directly owned 4,824,799 shares of the company’s stock, valued at $450,877,466.55. This trade represents a 7.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Tilak Mandadi sold 69,551 shares of CVS Health stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the completion of the transaction, the executive vice president owned 10,133 shares of the company’s stock, valued at approximately $907,714.14. This trade represents a 87.28% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 3,441,551 shares of company stock valued at $323,703,977 over the last ninety days. Corporate insiders own 0.85% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on CVS. Wall Street Zen raised shares of CVS Health from a “hold” rating to a “buy” rating in a research note on Thursday, July 23rd. Robert W. Baird boosted their price target on shares of CVS Health from $92.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 15th. JPMorgan Chase & Co. raised their price objective on CVS Health from $101.00 to $111.00 and gave the company an “overweight” rating in a research report on Tuesday, May 12th. Royal Bank Of Canada boosted their target price on CVS Health from $107.00 to $113.00 and gave the stock an “outperform” rating in a research report on Thursday, July 9th. Finally, Truist Financial increased their price target on CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Twenty-one investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and an average target price of $105.67.

CVS Health Price Performance

CVS stock opened at $107.05 on Tuesday. CVS Health Corporation has a 52 week low of $58.99 and a 52 week high of $110.68. The firm has a market capitalization of $136.59 billion, a P/E ratio of 47.16, a price-to-earnings-growth ratio of 1.05 and a beta of 0.61. The company has a fifty day simple moving average of $100.43 and a two-hundred day simple moving average of $86.35. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share for the quarter, topping analysts’ consensus estimates of $2.21 by $0.36. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. The firm had revenue of $100.43 billion for the quarter, compared to the consensus estimate of $94.99 billion. During the same period in the previous year, the firm posted $2.25 EPS. The business’s quarterly revenue was up 6.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Analysts anticipate that CVS Health Corporation will post 7.46 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd will be given a dividend of $0.665 per share. The ex-dividend date is Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.5%. CVS Health’s dividend payout ratio is 117.18%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.